{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:38:43Z","timestamp":1781001523774,"version":"3.54.1"},"reference-count":3,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.055","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T17:32:56Z","timestamp":1580232776000},"page":"2144-2148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Finding equipoise: CEPI revises its equitable access policy"],"prefix":"10.1016","volume":"38","author":[{"given":"Brenda","family":"Huneycutt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rotenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hatchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.12.055_b0005","unstructured":"Coalition for Epidemic Preparedness Innovations. CEPI\u2019s Equitable Access Policy, last updated December 20, 2018, https:\/\/cepi.net\/wp-content\/uploads\/2019\/01\/Equitable-Access-Policy.pdf [accessed August 21 2019]."},{"key":"10.1016\/j.vaccine.2019.12.055_b0010","unstructured":"Coalition for Epidemic Preparedness Innovations. Advancing Equitable Access to epidemic vaccines through CEPI\u2019s vaccine and platform development agreements, https:\/\/cepi.net\/wp-content\/uploads\/2019\/03\/Advancing-Equitable-Access_CEPI_29032019.pdf [accessed 21 August 2019]."},{"key":"10.1016\/j.vaccine.2019.12.055_b0015","unstructured":"Coalition for Epidemic Preparedness Innovations. Funding agreement and Terms and Conditions, https:\/\/cepi.net\/wp-content\/uploads\/2019\/03\/CfP3-TEMPLATE-Funding-Agreement-and-Terms-and-Conditions-.docx [accessed 21 August 2019]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19317190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19317190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:00Z","timestamp":1759401720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19317190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":3,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19317190"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finding equipoise: CEPI revises its equitable access policy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}